Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Cash Flow-to-Debt Ratio
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of CN¥2.40 Billion could theoretically repay 0% of its total liabilities (CN¥57.97 Billion) in one year. See Shanghai Fosun Pharmaceutical Group Co L free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Fosun Pharmaceutical Group Co L.
Annual Cash Flow-to-Debt Ratio for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shanghai Fosun Pharmaceutical Group Co Ltd. Check 600196 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥6.01 Billion | CN¥57.97 Billion | ▲ +33.1% |
| 2024 | 0.08x | CN¥4.48 Billion | CN¥57.53 Billion | ▲ +1.4% |
| 2023 | 0.08x | CN¥4.36 Billion | CN¥56.85 Billion | ▼ -3.5% |
| 2022 | 0.08x | CN¥4.22 Billion | CN¥53.05 Billion | ▼ -9.6% |
| 2021 | 0.09x | CN¥3.95 Billion | CN¥44.92 Billion | ▲ +28.5% |
| 2020 | 0.07x | CN¥2.58 Billion | CN¥37.70 Billion | ▼ -21.6% |
| 2019 | 0.09x | CN¥3.22 Billion | CN¥36.92 Billion | ▲ +9.4% |
| 2018 | 0.08x | CN¥2.95 Billion | CN¥36.96 Billion | ▼ -0.3% |
| 2017 | 0.08x | CN¥2.58 Billion | CN¥32.23 Billion | ▼ -29.7% |
| 2016 | 0.11x | CN¥2.11 Billion | CN¥18.52 Billion | ▲ +23.2% |
| 2015 | 0.09x | CN¥1.62 Billion | CN¥17.53 Billion | ▲ +25.1% |
| 2014 | 0.07x | CN¥1.20 Billion | CN¥16.23 Billion | ▼ -13.7% |
| 2013 | 0.09x | CN¥1.01 Billion | CN¥11.81 Billion | ▲ +31.3% |
| 2012 | 0.07x | CN¥665.52 Million | CN¥10.20 Billion | ▲ +125.0% |
| 2011 | 0.03x | CN¥316.65 Million | CN¥10.92 Billion | ▲ +5.9% |
| 2010 | 0.03x | CN¥203.36 Million | CN¥7.43 Billion | ▼ -52.2% |
| 2009 | 0.06x | CN¥261.87 Million | CN¥4.58 Billion | ▼ -24.0% |
| 2008 | 0.08x | CN¥233.04 Million | CN¥3.09 Billion | ▲ +78.7% |
| 2007 | 0.04x | CN¥131.48 Million | CN¥3.12 Billion | ▼ -31.9% |
| 2006 | 0.06x | CN¥184.91 Million | CN¥2.99 Billion | ▼ -8.1% |
| 2005 | 0.07x | CN¥188.35 Million | CN¥2.79 Billion | ▼ -22.5% |
| 2004 | 0.09x | CN¥205.10 Million | CN¥2.36 Billion | ▲ +27.6% |
| 2003 | 0.07x | CN¥150.14 Million | CN¥2.20 Billion | ▼ -2.4% |
| 2002 | 0.07x | CN¥102.47 Million | CN¥1.47 Billion | ▼ -9.3% |
| 2001 | 0.08x | CN¥68.15 Million | CN¥884.68 Million | ▼ -80.4% |
| 2000 | 0.39x | CN¥138.43 Million | CN¥352.61 Million | ▲ +106.7% |
| 1999 | 0.19x | CN¥38.20 Million | CN¥201.15 Million | ▼ -66.8% |
| 1998 | 0.57x | CN¥66.55 Million | CN¥116.36 Million | — |